Table 2 Performance of the independent testing set of the 237 neuroblastoma patients.
Neuroblastoma | SPC | SEN | ACC | MCC |
|---|---|---|---|---|
Module I | 0.910 | 0.500 | 0.865 | 0.375 |
Module II | 0.886 | 0.500 | 0.849 | 0.333 |
Neuroblastoma | SPC | SEN | ACC | MCC |
|---|---|---|---|---|
Module I | 0.910 | 0.500 | 0.865 | 0.375 |
Module II | 0.886 | 0.500 | 0.849 | 0.333 |